| LH/Mav |
body weight |
controlled perindopril content drinking water (1.5 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
body mass |
male |
119.0 days
| 8 |
380.0 |
g |
10.0 |
28.28 |
body weighing method |
0.0 |
|
|
|
103406 |
2824 |
| LH/Mav |
urine total protein excretion rate to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
total urine protein amount |
male |
161.0 days
| 10 |
57.68 |
mg/d/100 g |
4.34 |
13.72 |
pyrogallol red-molybdate complex-based urine total protein analysis |
0.0 |
|
|
|
102045 |
2645 |
| LH/Mav |
plasma total cholesterol level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood cholesterol amount |
male |
175.0 days
| 10 |
132.82 |
mg/dl |
8.11 |
25.64 |
automated plasma total cholesterol analysis |
0.0 |
|
|
|
102081 |
2645 |
| LH/Mav |
body weight |
controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
body mass |
male |
119.0 days
| 6 |
362.0 |
g |
8.0 |
19.6 |
body weighing method |
0.0 |
|
|
|
103407 |
2824 |
| LH/Mav |
plasma glucose level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood glucose amount |
male |
175.0 days
| 10 |
140.58 |
mg/dl |
3.96 |
12.52 |
automated plasma glucose analysis |
0.0 |
|
automated plasma glucose analysis (MMO:0000735) |
|
102089 |
2645 |
| LH/Mav |
plasma insulin level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 10 |
29.17 |
mU/l |
1.42 |
4.49 |
radioimmunoassay |
0.0 |
|
|
|
102093 |
2645 |
| LH/Mav |
plasma insulin level to plasma glucose level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood insulin amount |
male |
175.0 days
| 10 |
3.8 |
mU/mmol |
0.25 |
0.79 |
radioimmunoassay |
0.0 |
|
mU/mmol |
plasma insulin level to plasma glucose level ratio (CMO:0003555) |
102097 |
2645 |
| LH/Mav |
body weight |
controlled sodium chloride content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
body mass |
male |
119.0 days
| 7 |
407.0 |
g |
9.0 |
23.81 |
body weighing method |
0.0 |
|
|
|
103404 |
2824 |
| LH/Mav |
body weight |
controlled hydralazine content drinking water (75 mg/kg/d) (for 63 days) and controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and controlled reserpine content drinking water (0.75 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
body mass |
male |
119.0 days
| 7 |
383.0 |
g |
7.0 |
18.52 |
body weighing method |
0.0 |
|
|
|
103408 |
2824 |
| LH/Mav |
urine total protein excretion rate to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
total urine protein amount |
male |
175.0 days
| 10 |
55.26 |
mg/d/100 g |
3.51 |
11.1 |
pyrogallol red-molybdate complex-based urine total protein analysis |
0.0 |
|
|
|
102049 |
2645 |
| LH/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161.0 days
| 10 |
0.52 |
null |
0.03 |
0.09 |
flame photometry |
0.0 |
|
|
|
102069 |
2645 |
| LH/Mav |
urine sodium level to urine potassium level ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175.0 days
| 10 |
0.1 |
null |
0.01 |
0.03 |
flame photometry |
0.0 |
|
|
|
102073 |
2645 |
| LH/Mav |
plasma renin activity level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
renin activity |
male |
175.0 days
| 10 |
11.62 |
ng/ml/h |
2.24 |
7.08 |
plasma renin activity assay |
0.0 |
|
|
|
102077 |
2645 |
| LH/Mav |
plasma triglyceride level |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
blood triglyceride amount |
male |
175.0 days
| 10 |
0.99 |
mmol/l |
0.08 |
0.25 |
automated plasma triglyceride analysis |
0.0 |
|
automated plasma triglyceride analysis (MMO:0000734) |
|
102085 |
2645 |
| LH/Mav |
body weight |
controlled perindopril content drinking water (0.4 mg/kg/d) (for 63 days) then controlled sodium chloride content drinking water (2 %) (for 8 days) |
Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b. |
body mass |
male |
119.0 days
| 8 |
393.0 |
g |
7.0 |
19.8 |
body weighing method |
0.0 |
|
|
|
103405 |
2824 |
| LH/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
175.0 days
| 10 |
0.46 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
|
. |
102037 |
2645 |
| LH/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 14 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
175.0 days
| 10 |
0.45 |
mmol/l/100g |
0.02 |
0.06 |
flame photometry |
0.0 |
|
|
|
102061 |
2645 |
| LH/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
161.0 days
| 10 |
0.46 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
|
. |
102033 |
2645 |
| LH/Mav |
urine sodium level to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
urine sodium amount |
male |
161.0 days
| 10 |
2.76 |
mmol/l/100g |
0.24 |
0.76 |
flame photometry |
0.0 |
|
|
|
102057 |
2645 |